Qiagen Nv earnings were $92.9M for the trailing 12 months ending Sep 30, 2024, with -73.9% growth year over year. The latest QGEN earnings report on Sep 30, 2024 announced Q3 2024 earnings of $98.1M, down 153.4% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, QGEN reported annual earnings of $341.3M, with -19.4% growth.
QGEN past earnings growth
How has QGEN's earnings growth performed historically?
On QGEN's earnings call on Invalid Date, Qiagen Nv (NYSE: QGEN) reported Q3 2024 earnings per share (EPS) of $0.44, up 29.41% year over year. Total QGEN earnings for the quarter were $98.06 million. In the same quarter last year, Qiagen Nv's earnings per share (EPS) was $0.34.
As of the last Qiagen Nv earnings report, Qiagen Nv is currently profitable. Qiagen Nv's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $92.93 million, a 72.05% decrease year over year.
What was QGEN's earnings growth in the past year?
As of Qiagen Nv's earnings date in Invalid Date, Qiagen Nv's earnings has grown -73.88% year over year. This is 66.95 percentage points lower than the US Diagnostics & Research industry earnings growth rate of -6.92%. QGEN earnings in the past year totalled $92.93 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.